ChemoTech is an innovator in gentle cancer treatment and effective pain management.
ChemoTech has raised $644K in total funding. The most recent round was Post-IPO Debt. The last funding was announced in June 2026.
ChemoTech's investors include EISMEA, Gayathri Reddy, Harbir Singh Banga, Bengt Engström, Amitbir Singh Banga.
ChemoTech is headquartered in Lund, Sweden.
ChemoTech is an innovator in gentle cancer treatment and effective pain management.
ChemoTech is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ChemoTech — Funding & Investors." VCBacked, June 2, 2026, https://www.vcbacked.co/company/chemotech. Accessed October 22, 2026.
VCBacked. (2026). ChemoTech — Funding & Investors. Retrieved October 22, 2026, from https://www.vcbacked.co/company/chemotech
{{cite web |title=ChemoTech — Funding & Investors |url=https://www.vcbacked.co/company/chemotech |website=VCBacked |access-date=October 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated